Open access · US-GOV via ClinicalTrials.gov Clinical trial

Statins, Cholesterol and Cognitive Decline in Alzheimer's

Authors not listed

Karolinska Institutet · 2025

Loss of proteostasis Human Randomized controlled trial

Abstract

Disturbances in brain cholesterol homeostasis may be involved in the pathogenesis of Alzheimer's disease (AD). Lipid-lowering medications could interfere with neurodegenerative processes in AD through cholesterol metabolism or other mechanisms. The investigators aim to estimate the causal effect of statins on cognitive function measured by MMSE and to identify the mediating or modifying effect of cholesterol between statins and cognitive function in patients with Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-19 MST

Cite this

APA

Anonymous. (2025). Statins, Cholesterol and Cognitive Decline in Alzheimer's. <em>Karolinska Institutet</em>. https://clinicaltrials.gov/study/NCT06635252

Vancouver

Anonymous. Statins, Cholesterol and Cognitive Decline in Alzheimer's. Karolinska Institutet. 2025.

BibTeX

@misc{anon2025Statin, title = {Statins, Cholesterol and Cognitive Decline in Alzheimer's}, author = {Anonymous}, journal = {Karolinska Institutet}, year = {2025}, }